NUTLEY, NJ—Modern Meadow, a biofabrication company pioneering the creation of biologically advanced materials, is moving to a state-of-the-art laboratory and pilot manufacturing site at ON3, the former Hoffmann-La Roche campus in Nutley, NJ, helped in part by $32 million in Grow NJ tax credits from the New Jersey Economic Development Authority.
“We are excited to be part of the growing New Jersey biotech community,” says Modern Meadow CEO Andras Forgacs. “With this move, Modern Meadow is committed to expanding its biofabrication platform and continuing to build next-generation materials for the consumers of the future. We are thrilled to be in close proximity to a scientific talent pool and look forward to growing with Nutley.”
Modern Meadow was founded in 2011 to re-imagine animal materials, such as leather, by applying design and engineering to biology. With $53.5 million total funding to date, and this new 72,900-square-foot space to expand, the firm is now hiring and planning to add 200 new employees by 2020.
“We are thrilled to welcome Modern Meadow to the ON3 campus and look forward to expanding this site with more innovators across tech, entrepreneurship, medical education and retail,” says Gene Diaz, a principal partner with ON3 owner Prism Capital Partners.
“We were delighted to have strong support from both New York and New Jersey in planning this move. We’re eager to grow our headquarters in New Jersey while retaining a connection to the vibrant design and innovation ecosystem of New York,” says Forgacs. “Continuing our affiliation with START-UP NY, we are growing a design and applied research studio in Brooklyn, as part of the advanced manufacturing community at New Lab in the Navy Yard.”
William Hartman, executive managing director in Cushman & Wakefield’s New York office worked on the transaction with East Rutherford, NJ-based team members Curtis Foster and Jerry Shifrin.